author-photo

Martin R. Stockler

University of Sydney
National Health and Medical Research Council
Concord Repatriation General Hospital

445

Papers

9320

Citations

Citation Trend

Filter By

Papers (445) Sort By

Journal Conference Others

Clinical Trial Protocol for HyNOVA: Hyperthermic and Normothermic intraperitoneal chemotherapy following interval cytoreductive surgery for stage III epithelial OVArian, fallopian tube and primary peritoneal cancer (ANZGOG1901/2020)

2022 Journal of Gynecologic Oncology
Show All
- Source
- Cite
- Save
Citations (0)
P3BEP (ANZUP 1302): An international randomized phase III trial of accelerated versus standard BEP chemotherapy for male and female adults and children with intermediate and poor-risk metastatic germ cell tumors (GCTs).

2021 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Should I Have Adjuvant Immunotherapy? An Interview Study Among Adults with Resected Stage 3 Melanoma and Their Partners

2021 The Patient: Patient-Centered Outcomes Research
Show All
- Source
- Cite
- Save
Citations (1)
177Lu-PSMA-617 versus Cabazitaxel in Metastatic Castration-Resistant Prostate Cancer: a randomised, open-label, phase 2 trial (TheraP)

2021 The Journal of Nuclear Medicine
Show All
- Source
- Cite
- Save
Citations (0)
Overcoming enzalutamide resistance in metastatic prostate cancer by targeting sphingosine kinase.

2021 EBioMedicine
Show All
- Source
- Cite
- Save
Citations (1)
[177Lu]Lu-PSMA-617 versus cabazitaxel in patients with metastatic castration-resistant prostate cancer (TheraP): a randomised, open-label, phase 2 trial.

2021 The Lancet
Show All
- Source
- Cite
- Save
Citations (94)
RAMPART: A model for a regulatory-ready academic-led phase III trial in the adjuvant renal cell carcinoma setting.

2021 Contemporary Clinical Trials
Show All
- Source
- Cite
- Save
Citations (1)
Adjuvant chemotherapy following chemoradiation as primary treatment for locally advanced cervical cancer compared to chemoradiation alone: The randomized phase III OUTBACK Trial (ANZGOG 0902, RTOG 1174, NRG 0274).

2021 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (8)
596P Impact of combined lipidomic and genetic aberrations on clinical outcomes in metastatic castration-resistant prostate cancer (mCRPC)

2021 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Tumor-associated immune cells and progression-free survival in advanced endometrial cancer (EC), results from the PHAEDRA trial (ANZGOG 1601).

2021 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)